STAT3 INHIBITOR FORMULATION Read more about STAT3 INHIBITOR FORMULATION United Kingdom18720845.9Filed on 2018-04-05
STAT3 INHIBITOR FORMULATION Read more about STAT3 INHIBITOR FORMULATION France18720845.9Filed on 2018-04-05
STAT3 INHIBITOR FORMULATION Read more about STAT3 INHIBITOR FORMULATION Spain18720845.9Filed on 2018-04-05
STAT3 INHIBITOR FORMULATION Read more about STAT3 INHIBITOR FORMULATION Germany18720845.9Filed on 2018-04-05
METHODS OF PRODUCING T CELL POPULATIONS USING HYDROXYCITRIC ACID AND/OR A SALT THEREOF Read more about METHODS OF PRODUCING T CELL POPULATIONS USING HYDROXYCITRIC ACID AND/OR A SALT THEREOF Hong Kong62021038049.4Filed on 2021-09-02
T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS Read more about T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS New Zealand779633Filed on 2021-09-02
T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS Read more about T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS China202111083392.9Filed on 2021-09-15
CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN Read more about CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN India202148039207Filed on 2021-08-30
CHIMERIC ADAPTOR AND KINASE SIGNALING PROTEINS AND THEIR USE IN IMMUNOTHERAPY Read more about CHIMERIC ADAPTOR AND KINASE SIGNALING PROTEINS AND THEIR USE IN IMMUNOTHERAPY US Application 17/475,810Filed on 2021-09-15
Use Of TomentosenalA For Treatment Of Skin Conditions Read more about Use Of TomentosenalA For Treatment Of Skin Conditions Australia2021902329Filed on 2021-07-29